Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A multicenter, randomized, double-blind, parallel-group study to investigate the glucose lowering effect, safety and tolerability of a 24 week treatment with Vildagliptin 100 mg o.a.d. versus placebo followed by a 12 week treatment period with open-label Vildagliptin 100 mg o.a.d. as add-on therapy in patients with type 2 diabetes inadequately controlled with Metformin monotherapy https://kusajili.com:443/Trial/H7YpWSr0l02oGLwuxNV17w%24a-multicenter-randomized-double-blind-parallel-group-study-to-investigate-the-glucose-lowering-effect-safety-and-tolerability-o
I have read and accept the terms of use of the site and the Privacy Policy
Send your message